Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EpiSC-derived dopaminergic progenitors
- Development stage
- Preclinical
- Lead developer
- Sumitomo Pharma
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intralesional
01
Overview
EpiSC-derived dopaminergic progenitors are midbrain dopaminergic (DAergic) precursor cells generated from mouse epiblast stem cells (EpiSCs) through a stepwise differentiation protocol involving the control of FGF signaling. These cells are primarily utilized as a research tool in preclinical studies for Parkinson's disease (PD) to evaluate cell-replacement strategies. In mouse allograft models, these progenitors have demonstrated the ability to survive, differentiate into mature tyrosine hydroxylase (TH)-positive neurons, and provide functional motor recovery comparable to the gold-standard primary fetal ventral mesencephalon (VM) tissue. They are currently used in academic research settings to study the efficacy and safety of pluripotent stem cell-derived transplants in neurodegenerative disease models.
- Other names
- EpiSC-derived DAergic progenitorsepiblast stem cell-derived dopaminergic progenitorsmouse epiblast stem cell-derived dopaminergic progenitors
Beyond the preview
Go deeper on EpiSC-derived dopaminergic progenitors.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EpiSC-derived dopaminergic progenitors.